Results 11 to 20 of about 836,416 (221)
Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors
Adaptive immune recognition is mediated by specific interactions between heterodimeric T cell receptors (TCRs) and their cognate peptide-MHC (pMHC) ligands, and the methods to accurately predict TCR:pMHC interaction would have profound clinical ...
Chloe H. Lee+8 more
doaj +1 more source
Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
Chimeric antigen receptor (CAR) T cell therapy has shown unprecedented success in treating advanced hematological malignancies. Its effectiveness in solid tumors has been limited due to heterogeneous antigen expression, a suppressive tumor ...
Navid Ghahri-Saremi+5 more
doaj +1 more source
Regulator T Cells: Specific for Antigen and/or Antigen Receptors? [PDF]
AbstractAdaptive immune responses are regulated by many different molecular and cellular effectors. Regulator T cells are coming to their rights again, and these T cells seem to have ordinary α/β T‐cell receptors (TCRs) and to develop in the thymus. Autoimmune responses are tightly regulated by such regulatory T cells, a phenomenon which is beneficial ...
B. Rubin+3 more
openaire +3 more sources
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers
Antigen escape represents a potential drawback of chimeric antigen receptor T cell (CAR-T) therapy targeting a single tumor-associated antigen. To reduce the risk of antigen escape, here the authors report the design and characterization of a BAFF ligand
Derek P. Wong+12 more
doaj +1 more source
Chimeric antigen receptors (CARs) targeting CD19 have mediated dramatic antitumor responses in hematologic malignancies, but tumor regression has rarely occurred using CARs targeting other antigens.
Adrienne H. Long+14 more
semanticscholar +1 more source
Comparison of lentiviral and sleeping beauty mediated αβ T cell receptor gene transfer. [PDF]
Transfer of tumour antigen-specific receptors to T cells requires efficient delivery and integration of transgenes, and currently most clinical studies are using gamma retroviral or lentiviral systems.
Anne-Christine Field+9 more
doaj +1 more source
T cell antigen discovery via Signaling and Antigen presenting Bifunctional Receptors
CD8+ T cells recognize and eliminate tumors in an antigen-specific manner. Despite progress in characterizing the antitumor T cell repertoire and function, the identification of target antigens remains a challenge.
Alok V. Joglekar+11 more
semanticscholar +1 more source
The second touch hypothesis states that T cell activation, proliferation, induction of homing receptors and polarization are distinguishable and, at least in part, sequential. The second touch hypothesis maintains that full T cell polarization requires T
Klaus Ley
doaj +1 more source
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
To redirect T cells against tumor cells, T cells can be engineered ex vivo to express cancer-antigen specific T cell receptors (TCRs), generating products known as TCR-engineered T cells (TCR T).
Paul Shafer+7 more
doaj +1 more source
High-throughput determination of the antigen specificities of T cell receptors in single cells
We present tetramer-associated T-cell receptor sequencing (TetTCR-seq) to link T cell receptor (TCR) sequences to their cognate antigens in single cells at high throughput.
Shuqi Zhang+8 more
semanticscholar +1 more source